Tracker
CDSCO
124 notices, January 1 to December 29, 2025
Updated
How the drug, device and cosmetic rules work, from licences to trials: our CDSCO guide.
December 2025
- Notification regarding Nimesulide above 100 mg in immediate release dosage form, PDF, opens in a new tab
S.O. 6091(E) ·
- Draft notification for Removal of Syrup exemption under schedule K, PDF, opens in a new tab
Made final by G.S.R. 477(E) (PDF, opens in a new tab) of June 9, 2026
G.S.R. 927(E) ·
- Cancellation of registration of cosmetic product QR 678- Neo issued under RC/COS-OO1410 for import of Cosmetics under the Cosmetics Rules, 2020, PDF, opens in a new tab
- List of Ethics Committees cancelled by CLA, PDF, opens in a new tab
- MedTech Mitra's In-Vitro Diagnostic Innovators Handbook, PDF, opens in a new tab
- New provision for Risk Classification of Medical Devices on the CDSCO Online System for Medical Devices, PDF, opens in a new tab
- Draft Notification for amendment in Medical Device Rules, 2017, PDF, opens in a new tab
G.S.R. 883(E) ·
November 2025
- Risk classification list of medical devices pertaining to Interventional Radiology, PDF, opens in a new tab
- Risk classification list of medical devices pertaining to Radiotherapy, PDF, opens in a new tab
- Display of QR Code at retail/wholesale pharmacies across the country to report Adverse Drug Reactions to PvPI, PDF, opens in a new tab
- Requirement of License issued by CDSCO/State Licensing Authorities in procurement of Medical Devices by procurement agencies, PDF, opens in a new tab
October 2025
- Dated 31.10.2025 Corrigendum to G.S.R 587( E) Dated 27.08.2025 regarding Draft Notification for application of unapproved drugs for conduct of BA BE studies for export purpose under NDCT Rules 2019, PDF, opens in a new tab
G.S.R. 810(E), G.S.R. 587(E) ·
- Risk based classification list of Class A(non-sterile and non-measuring) medical device, PDF, opens in a new tab
- Post Approval changes for clinical trials (Form CT-06) for CGTP through SUGAM Online Portal, PDF, opens in a new tab
- Digital Monitoring System on the ONDLS portal for monitoring the supply chain of high-risk solvents, PDF, opens in a new tab
- The list of standards published under Medical Equipment and Hospital Planning (MHD) of BIS as forwarded in 2025, PDF, opens in a new tab
- Draft Notification regarding Debarment of applicant for submitting misleading, or fake, or Fabricated Documents, information, PDF, opens in a new tab
Made final by G.S.R. 706(E) (PDF, opens in a new tab) of July 30, 2026
G.S.R. 756(E) ·
- Notification regarding restriction of sale of drug products containing alcohol content under Drugs Rules 1945, PDF, opens in a new tab
Made final by G.S.R. 607(E) (PDF, opens in a new tab) of July 8, 2026
G.S.R. 760(E) ·
- Notification of liquid anticeptic for household use or hospital and ohter than household use under Drug Rules, PDF, opens in a new tab
G.S.R. 759(E) ·
- Inclusion of additional items under CLAA in Drugs Rules 1945, PDF, opens in a new tab
Made final by G.S.R. 530(E) (PDF, opens in a new tab) of June 29, 2026
G.S.R. 758(E) ·
- Amendment under Drugs Rules to include more categories under Schedule H2, PDF, opens in a new tab
Made final by G.S.R. 506(E) (PDF, opens in a new tab) of June 22, 2026
G.S.R. 757(E) ·
- Inclusion of Qualifications of Inspector Medical Devices and Government Analyst, PDF, opens in a new tab
Made final by G.S.R. 165(E) (PDF, opens in a new tab) of March 2, 2026
G.S.R. 748(E) ·
- Circular to all State/UTs Licensing Authorities regarding recent revised GST rate Structure, PDF, opens in a new tab
- Circular to all Zonal/Sub Zonal Offices of CDSCO regarding recent revised GST rate Structure, PDF, opens in a new tab
- Circular to all Pharma/MedTech and Cosmetics Industry Associations regarding recent revised GST rate Structure, PDF, opens in a new tab
- Circular to all Chemists and Druggists Associations regarding recent revised GST rate Structure, PDF, opens in a new tab
- Circular to all Internet Pharmacy Associations regarding recent revised GST rate Structure, PDF, opens in a new tab
- Notice for inviting comment to ensure a level playing field in new drug approval in India, PDF, opens in a new tab
- Strict compliance with the Drugs Rules 1945 for testing of raw materials and finished formulations, PDF, opens in a new tab
- Mapping of ICEGATE with CDSCO-Notified Ports, PDF, opens in a new tab
September 2025
- Clarification for grant of permission for combipack product of lyophilised dry powder for injection /I.V infusion and diluents for reconstitution such as sterile water for injection / sodium Chloride Injection, PDF, opens in a new tab
- Processing of Grant of WHO GMP COPP applications in respect of products under consideration for license approval through ONDLS Portal, PDF, opens in a new tab
- Prohibit the import, manufacture, sale and distribution of certain antimicrobial products for animal use, PDF, opens in a new tab
From the draft S.O. 2298(E) (PDF, opens in a new tab) of May 22, 2025
S.O. 4338(E) ·
- Circular Internal time-lines Procedures for RTI Appeals, PDF, opens in a new tab
- ICMR-CDSCO Standard Performance Evaluation Protocols, PDF, opens in a new tab
- Surrender of RC No. RC/COS-002850 valid upto 13'Dec-2026 issued to you for the purpose of import of cosmetics manufactured by M/s. Allergan Sales LLC, 2525 Dupont Drive,lrvine,CA 92612, PDF, opens in a new tab
- Separate provision for subsequent Importer in Online system for Medical Devices, PDF, opens in a new tab
- Clarification for regulatory pathway for Cocrystals, PDF, opens in a new tab
- Withdrawal / cancellation of product permission for not Implementing of GSR 327 (E) dated 03.04.2027 for obtaining result of bio-equivalence study before grant of manufacturing license of oral dosage form of drugs falling under the Category II and Category IV of this Biopharmaceutical Classification System, PDF, opens in a new tab
G.S.R. 327(E) ·
- Stickering on Medical Products due to reduction in Goods Service Tax (GST) rate, PDF, opens in a new tab
- Corrigendum to the letter dated 11.04.2025 on manufacturing and marketing of unapproved FDCs, PDF, opens in a new tab
- Inviting comments on consideration of the proposal regarding problem faced by the blind or visually impaired people to read medicines tablets/capsules strips, PDF, opens in a new tab
- Acceptance of the IBSC approval for seeking permission to manufacture test items for examination, test and analysis through form CT-10 as per the recommendation of the 314th RCGM meeting, dated 09.07.2025, PDF, opens in a new tab
August 2025
- Availability of Not Standard Quality (NSQ) Alert on New Link in CDSCO Website, PDF, opens in a new tab
- Draft Notification about changes to requirements of Test license under NDCT Rules 2019, PDF, opens in a new tab
Made final by G.S.R. 46(E) (PDF, opens in a new tab) of January 20, 2026
G.S.R. 588(E) ·
- Draft Notification for application of unapproved drugs for conduct of BA BE studies for export purpose under NDCT Rules 2019, PDF, opens in a new tab
Made final by G.S.R. 50(E) (PDF, opens in a new tab) of January 21, 2026
G.S.R. 587(E) ·
- Inviting comments on standard IVD evaluation protocols drafted by ICMR and CDSCO, PDF, opens in a new tab
- Cancellation of products under RC/COS-003827, for import of Cosmetics under Cosmetics Rules, 2020, PDF, opens in a new tab
- Income Tax Circular regarding Tax regime and Savings dated 19.08.2025, PDF, opens in a new tab
- Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 391(E) (PDF, opens in a new tab) of July 12, 2024
G.S.R. 554(E) ·
- Inviting comments on standard IVD evaluation protocol drafted by ICMR and CDSCO 3, PDF, opens in a new tab
- COVID-19 vaccines approved in the country as on 11.08.2025, PDF, opens in a new tab
- Reminder of COPP Circular for Grant of WHO GMP COPP through ONDLS Portal, PDF, opens in a new tab
- Surrender RC letter dated 04.08.2025 (M/s. NKG Advisory Business and Consulting Services Pvt. Ltd), PDF, opens in a new tab
- Circular for New online Dual Use System on SUGAM Portal, PDF, opens in a new tab
- Appointment of Compounding Authority under the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, PDF, opens in a new tab
S.O. 3551(E) ·
July 2025
- Certain amendments in Cosmetics Rule 2020, PDF, opens in a new tab
From the draft G.S.R. 371(E) (PDF, opens in a new tab) of May 15, 2023
G.S.R. 513(E) ·
- Visitors management FDA Bhawan, PDF, opens in a new tab
- Issues related to safety of Ranitidine drug due to presence of NDMA impurity, PDF, opens in a new tab
- CDSCO Visitor Online System, PDF, opens in a new tab
- Circulars regarding CDSCO Visitor Online System, PDF, opens in a new tab
- Training schedule for the grant of WHO GMP (COPP) through ONDLS portal to be conducted from 21.07.2025 to 13.08.2025 by zonal and sub Zonal Office CDSCO, PDF, opens in a new tab
- THE SUBJECT EXPERT COMMITTEES GUIDANCE DOCUMENT, PDF, opens in a new tab
- Revised Export NOC Guidance document for Manufacture of Unapproved / Approved New Drugs along with Annexures, PDF, opens in a new tab
- Extension of timeline for grant of WHO GMP COPP through ONDLS portal, PDF, opens in a new tab
- Clinical Trial Applications (Phase I, Il and III) for Cell and Gene Therapeutics Products through SUGAM Online portal system, PDF, opens in a new tab
- Circular regarding online Sugam portal for CT-04 applications of CELL & GENE THERAPEUTICS PRODUCTS through SUGAM Online Portal System, PDF, opens in a new tab
- DCGI Public Hearing Form for applicants, PDF, opens in a new tab
June 2025
- Grant of WHO-GMP COPP through ONDLS portal, PDF, opens in a new tab
- Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules 2017, PDF, opens in a new tab
- Circular regarding Celebration of 10th Anniversary of International Day of Yoga 2025, PDF, opens in a new tab
- Antimicrobial Resistance AMR Mitigation, PDF, opens in a new tab
- To Share the list of drug products manufacturing permissions issued by State licensing Authority SLA/FDA including antibiotics, FDCs and their premixes for Veterinary use, PDF, opens in a new tab
- Reconstituted Internal Complaint Committee on Sexual Harassment, PDF, opens in a new tab
- CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 04.06.2025, PDF, opens in a new tab
May 2025
- Draft notification for amendment in certain Drugs Rules (Related to Rule 121 – Test for Pyrogen, Footnote of Schedule H, condition of license under Form 20B, 20BB, 21B, 21BB, inclusion of name of competent person in Form 20G), PDF, opens in a new tab
Made final by G.S.R. 135(E) (PDF, opens in a new tab) of February 16, 2026
G.S.R. 345(E) ·
- Guidance document on disposal of expired/ unused drugs, PDF, opens in a new tab
- Office Memorandum regarding Clarification of Comprehensive permission for products imported for overprinting/stickering/stamping as per Rule 104A of Drugs and Cosmetics Rules 1945, PDF, opens in a new tab
- Appointment of CPIO for the purpose of RTI Technical Matters, PDF, opens in a new tab
- Notification to prohibit the import, manufacture, sale and distribution of certain antimicrobial products for animal use, PDF, opens in a new tab
Made final by S.O. 4338(E) (PDF, opens in a new tab) of September 23, 2025
S.O. 2298(E) ·
- Cancellation of products under RC/COS-003211, for import of Cosmetics under Cosmetics Rules, 2020, PDF, opens in a new tab
- Circular regarding Withdrawn dated 16.05.2025, PDF, opens in a new tab
- And S.O. 2209 Notification of Director Incharge, CDL Kolkata, PDF, opens in a new tab
S.O. 2208, S.O. 2209 ·
- Migration from NPS to UPS, PDF, opens in a new tab
- Suo-Moto Disclosure of Information Pertaining to CDSCO-HQ, Zonal, Sub-Zonal, Port Offices, and Laboratories for Third-Party Transparency Audit, PDF, opens in a new tab
- Inviting comments on Revised Guidelines on Similar Biologics- Regulatory requirements for Marketing Authorization in India, 2025 drafted by CDSCO, PDF, opens in a new tab
April 2025
- Public Notice on PRO Schedule, PDF, opens in a new tab
- Circular regarding introduction of Tooltips for legal forms in SUGAM and Medical Device Online Portals to Assist Stakeholders, PDF, opens in a new tab
- Notification reg rules for Compounding of offences under Jan Vishwas Act, PDF, opens in a new tab
From the draft G.S.R. 374(E) (PDF, opens in a new tab) of July 10, 2024
G.S.R. 259(E) ·
- Restriction of the Fixed Dose Combination of Chlorpheniramine Maleate and Phenylephrine Hydrochloride, PDF, opens in a new tab
S.O. 1717(E) ·
- Manufacturing and marketing of unapproved FDCs regarding, PDF, opens in a new tab
- Examination of 2nd assessment report of Prof. Kokate Committee by Drugs Technical Advisory Board (DTAB) in its meeting dated 26.09.2022, PDF, opens in a new tab
- Provision for system auto-generated Neutral code by the manufacturer for the export purpose under Medical Devices Rules, 2017, PDF, opens in a new tab
- Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licensed medical device, PDF, opens in a new tab
- Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licenced medical device, PDF, opens in a new tab
- Transfer of Drugs (API/Formulations) from Special Economic Zone (SEZ) to Domestic Tariff Area (DTA), PDF, opens in a new tab
- Prohibits to import manufacture sale and distribution and use in any food producing animal rearing system of drug formulations containing Chloramphenicol or Nitrofurans drug with immediate effect, PDF, opens in a new tab
- Draft risk based classification list Cardiovascular and Neurological dated 01 04 2025 for stakeholder comments, PDF, opens in a new tab
March 2025
- OM dated 27.03.2025 regarding Exemption of sampling and testing of orphan drugs at CDSCO Port office, PDF, opens in a new tab
- Notification of Government Analysts at National Institute of Biologicals, Noida, PDF, opens in a new tab
S.O. 203(E) ·
- Surrender of lmport Registration Certificate under Cos-4A vide IRN/COS- 4N20221 000001 dated 29.04.2022 and I RN/COS- 4N20221 000006 dated 14.08.2022, PDF, opens in a new tab
- On line application for extension of time to comply with revised Sch M on ONDLS portal, PDF, opens in a new tab
- PAC Cancellation letter dated 12.03.2025 FSN brands Marketing Pvt Ltd, PDF, opens in a new tab
- Reconstitution of Drugs Technical Advisory Board (DTAB), PDF, opens in a new tab
S.O. 1159(E) ·
- Banning of Chloramphenicol and Nitrofurans in food rearing animal systems, PDF, opens in a new tab
S.O. 1158(E) ·
- Launching of registration of Clinical Research Organisation applications through SUGAM Portal, PDF, opens in a new tab
February 2025
- Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority 24 Feb 2025, PDF, opens in a new tab
- Submission of clinical trial site addition and change of principal Investigator applications through sugam portal, PDF, opens in a new tab
- Gastro Resistant Tablets/Capsules Delayed Release Tablets/Capsules as New Drugs as per Rule 2 (1)(w) of the New Drugs and Clinical Trials Rules 2019, PDF, opens in a new tab
- Office Order regarding Renaming of PSUR/PV/AEFI Division in CDSCO HQ, PDF, opens in a new tab
- Prohibits to manufacture, sale and distribution and use of drug Nimesulide and its formulation for animal use with immediate effect, PDF, opens in a new tab
- Inviting stakeholders comments for Invitro Diagnostic Medical Device adverse event reporting form, PDF, opens in a new tab
- Additonal varant circular on 12.02.2025, PDF, opens in a new tab
- Notification reg Extension of timeline for implementation of Schedule M, PDF, opens in a new tab
From the draft G.S.R. 10(E) (PDF, opens in a new tab) of January 4, 2025
G.S.R. 127(E) ·
- Procedure to be followed for subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCG(I), PDF, opens in a new tab
January 2025
- Notification of IVRI Veterinary Government Analyst, PDF, opens in a new tab
S.O. 558(E) ·
- Inviting comments on standard IVD evaluation protocol drafted by ICMR and CDSCO 2, PDF, opens in a new tab
- Guidance document Validation of Rapid Diagnostics for Pathogen Identification and Antimicrobial Susceptibility Testing (AST), PDF, opens in a new tab
- Grant of manufacturing licences for Large Volume Parenterals (Form 28D/Form 28DA) and endorsement of additional products in the licence through ONDLS portal, PDF, opens in a new tab
- Shifting of CDSCO Sub Zonal office from AIIMS Department of Pharmacology Level 4 A5 Block Medical College Virbhadra Road Rishikesh Uttrakhand, PDF, opens in a new tab
- Updation of exisiting risk based classification list draft dated 06 01 2025 for stakeholder comments, PDF, opens in a new tab
- Corrigendum to G.S.R 10(E) dated 04.01.2025 reg Extension of Schedule M, PDF, opens in a new tab
G.S.R. 11(E), G.S.R. 10(E) ·
- Notification for Extension of Schedule M, PDF, opens in a new tab
Made final by G.S.R. 127(E) (PDF, opens in a new tab) of February 11, 2025
G.S.R. 10(E) ·
- Merged existing Medical Devices risk-classification, PDF, opens in a new tab